Poor clinical outcomes associated to multimorbidity, frailty and malnutrition in patients with atrial fibrillation

Autor: Eva Soler-Espejo, Beatriz Ángela Zazo-Luengo, José Miguel Rivera-Caravaca, Raquel López-Gávez, María Asunción Esteve-Pastor, Gregory Y.H. Lip, Francisco Marín, Vanessa Roldán

Publikováno v: The Journal of Nutrition, Health and Aging, Vol 29, Iss 1, Pp 100430- (2025)

Background: Atrial fibrillation (AF) patients often present with a higher prevalence of comorbidities, frailty, and malnutrition. We investigated if multimorbidity, frailty and malnutrition were associated with clinical outcomes in patients with AF s

Externí odkaz: https://doaj.org/article/595bd8b2c4bd478e91424e8dea07f46e

Transhumanist Contraceptives in June Caldwell’s “The Implant”

Autor: Romero, Vanessa Roldán

Publikováno v: Journal of Posthuman Studies, 2020 Aug 01. 4(1), 96-106.

Externí odkaz: https://www.jstor.org/stable/10.5325/jpoststud.4.1.0096

Factor XII in PMM2-CDG patients: role of N-glycosylation in the secretion and function of the first element of the contact pathway

Autor: Raquel López-Gálvez, María Eugenia de la Morena-Barrio, Alberto López-Lera, Monika Pathak, Antonia Miñano, Mercedes Serrano, Delphine Borgel, Vanessa Roldán, Vicente Vicente, Jonas Emsley, Javier Corral

Publikováno v: Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-10 (2020)

Abstract Background Congenital disorders of glycosylation (CDG) are rare diseases with impaired glycosylation and multiorgan disfunction, including hemostatic and inflammatory disorders. Factor XII (FXII), the first element of the contact phase, has

Externí odkaz: https://doaj.org/article/4bb121c4421d4dd596db13a4bed5ae77

ALG12‐CDG: An unusual patient without intellectual disability and facial dysmorphism, and with a novel variant

Autor: María Eugenia de laMorena‐Barrio, María Sabater, Belén de laMorena‐Barrio, Renee L. Ruhaak, Antonia Miñano, José Padilla, Mara Toderici, Vanessa Roldán, Juan R. Gimeno, Vicente Vicente, Javier Corral

Publikováno v: Molecular Genetics & Genomic Medicine, Vol 8, Iss 8, Pp n/a-n/a (2020)

Abstract Background Congenital disorder of glycosylation (CDG) type I is a group of rare disorders caused by recessive mutations in up to 25 genes that impair the N‐glycan precursor formation and its transfer to proteins resulting in hypoglycosylat

Externí odkaz: https://doaj.org/article/08b7aebd3a134b4985f9255090063400

Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry

Autor: María A Esteve-Pastor, José M Rivera-Caravaca, Vanessa Roldán, Marcelo Sanmartin Fernández, Fernando Arribas, Jaime Masjuan, Vivencio Barrios, Juan Cosin-Sales, Román Freixa-Pamias, Esther Recalde, Alejandro I Pérez-Cabeza, José Manuel Vázquez Rodríguez, Carles Ràfols Priu, Manuel Anguita Sánchez, Gregory Y H Lip, Francisco Marin

Publikováno v: Esteve-Pastor, M A, Rivera-Caravaca, J M, Roldán, V, Fernández, M S, Arribas, F, Masjuan, J, Barrios, V, Cosin-Sales, J, Freixa-Pamias, R, Recalde, E, Pérez-Cabeza, A I, Rodríguez, J M V, Priu, C R, Sánchez, M A, Lip, G Y H & Marin, F 2023, ' Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban : Observations from the prospective EMIR Registry ', European heart journal. Cardiovascular pharmacotherapy, vol. 9, no. 1, pp. 38-46 . https://doi.org/10.1093/ehjcvp/pvac060

Background Assessing bleeding risk during the decision-making process of starting oral anticoagulation (OAC) therapy in atrial fibrillation (AF) patients is essential. Several bleeding risk scores have been proposed for vitamin K antagonist users but

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cbffcb0afd9e1a00c1add23c67a0313
https://doi.org/10.1093/ehjcvp/pvac060